ribosomal protein S10 pseudogene 7Genealiases: RPS10_2_147 · lnc-MCEI
Q-omics provides the consensus-scored RPS10P7 profile across patient tissues and cancer cell-line models. RPS10P7 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, RPS10P7 is differentially expressed in 8, with the highest sampling consensus in THCA. Additionally, RPS10P7 RNA expression shows 18,635 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KIRC, THCA, and UVM as cancer lineages where RPS10P7 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS10P7 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS10P7 survival associations across molecular data types. RPS10P7 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS10P7 RNA expression–survival associations across cancer types. High RPS10P7 expression shows unfavorable associations in KIRC, UVM and LGG, but favorable associations in PAAD, STAD and READ. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for RPS10P7 RNA expression.
This table summarizes RPS10P7 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPS10P7. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS10P7 shows lower tumor expression in THCA and KIRC and higher tumor expression in HNSC, LUAD, BLCA and LUSC. The THCA box plot shows higher RPS10P7 RNA expression in normal versus tumor tissue (log2 FC = −0.994, t-test p < 0.001).
This table shows molecular features associated with RPS10P7 in patient tissues and cancer cell lines. In patient samples, RPS10P7 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set. In cancer cell lines, RPS10P7 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD.
